US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY MANAGED FUTURES STRATEGY ETF

30.12

+0.74002.52%

Post-market: 30.120.00000.00%17:03 EDT

Volume:1.13M

Turnover:33.79M

Market Cap:1.50B

PE:- -

High:30.27

Open:29.80

Low:29.80

Close:29.38

52wk High:30.92

52wk Low:26.36

Shares:49.65M

Float Shares:49.65M

Volume Ratio:0.83

T/O Rate:2.27%

Dividend:1.12

Dividend Rate:3.72%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Institutions Have Sold Over $100 Billion in US Stocks, Goldman Sachs Suggests April Rebound Window May Be Opening

Unveiling the Liquidation Storm Behind High Leverage in Precious Metals

Hedge Funds Suffer Worst Losses Since "Liberation Day" as Iran Conflict Upends Traditional Diversification

Goldman Sachs Trader Warns: Market Correction Not Over, CTA Strategies Still Face Nearly $100 Billion in Pending Sell Pressure

Press Release: Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results

Oil Price Surge Triggers Asia-Pacific Market Plunge

Hedge Funds Face Largest Drawdown Since April Last Year, Particularly Equity Long-Short Strategies Overweight in Europe and Korea

Systemic Selling Pressure Set to Intensify as Major Banks Warn of Structural Vulnerabilities

Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders

Press Release: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Press Release: Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

Pew Applauds Milestone Ratification of International Treaty to Improve Safety at Sea

XTransfer Debuts at the CES in Vegas

Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome

CES Chairperson: Robots Take Center Stage This Year | On the Ground at CES

Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category

WHAT NOT TO MISS AT CES 2026

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

VSure and HEYDOC Health Introduce CareConnect Suite, Transforming SME Protection and Digital Healthcare in Malaysia

ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CTA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","market":"US","secType":"STK","nameCN":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","latestPrice":30.12,"timestamp":1774641600000,"preClose":29.38,"halted":0,"volume":1127738,"hourTrading":{"tag":"盘后","latestPrice":30.12,"preClose":30.12,"latestTime":"17:03 EDT","volume":38,"amount":1145.11,"timestamp":1774645410640,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02518720217835269,"floatShares":49650001,"shares":49650001,"eps":0,"marketStatus":"Market Closed","change":0.74,"latestTime":"03-27 16:00:00 EDT","open":29.8,"high":30.2723,"low":29.8,"amount":33792721.045948,"amplitude":0.016076,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":29.38,"sharesOutstanding":45800001,"nav":29.5584,"aum":1467576769.38,"dividendRate":0.037165,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":29.89,"preClose":29.38,"latestTime":"09:10 EDT","volume":822,"amount":23823.809814,"timestamp":1774617044213,"change":0.51,"changeRate":0.017359,"amplitude":0.047311},"postHourTrading":{"tag":"盘后","latestPrice":30.12,"preClose":30.12,"latestTime":"17:03 EDT","volume":38,"amount":1145.11,"timestamp":1774645410640,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8336767006626137,"impliedVol":0.118,"impliedVolPercentile":0.6414},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTA\",,,,,undefined,":{"symbol":"CTA","floatShares":49650001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8336767006626137,"shares":49650001,"dividePrice":1.1194,"high":30.2723,"amplitude":0.016076,"preClose":29.38,"low":29.8,"week52Low":26.36,"pbRate":"--","week52High":30.92,"institutionHeld":0,"latestPrice":30.12,"eps":0,"divideRate":0.037165,"volume":1127738,"delay":0,"ttmEps":0,"open":29.8,"prevYearClose":27.26,"prevWeekClose":30.37,"prevMonthClose":30.24,"prevQuarterClose":27.26,"fiveDayClose":30.37,"twentyDayClose":30.24,"sixtyDayClose":27.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTA\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"CTA","amount":0.15,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2026-02-24","symbol":"CTA","amount":0.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-24","defaultRemindTime":1771943400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-24","currency":"USD","dateTimestamp":1771909200000,"payDate":"2026-02-27"},{"date":"2026-01-27","symbol":"CTA","amount":0.1,"announcedDate":"2026-01-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-27","defaultRemindTime":1769524200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-27","currency":"USD","dateTimestamp":1769490000000,"payDate":"2026-01-30"},{"date":"2025-11-21","symbol":"CTA","amount":0.1,"announcedDate":"2025-11-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-21","defaultRemindTime":1763735400000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-21","currency":"USD","dateTimestamp":1763701200000,"payDate":"2025-11-28"},{"date":"2025-10-28","symbol":"CTA","amount":0.1,"announcedDate":"2025-10-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-28","defaultRemindTime":1761658200000,"name":"SIMPLIFY MANAGED FUTURES STRATEGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-31","payableDate":"2025-10-28","currency":"USD","dateTimestamp":1761624000000,"payDate":"2025-10-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTA\",market:\"US\",,,undefined,":[{"executeDate":"2022-08-26","recordDate":"2022-08-29","paymentDate":"2022-08-31","value":0.15,"currency":"USD"},{"executeDate":"2022-09-27","recordDate":"2022-09-28","paymentDate":"2022-09-30","value":0.15,"currency":"USD"},{"executeDate":"2022-10-26","recordDate":"2022-10-27","paymentDate":"2022-10-31","value":0.15,"currency":"USD"},{"executeDate":"2022-11-25","recordDate":"2022-11-28","paymentDate":"2022-11-30","value":0.15,"currency":"USD"},{"executeDate":"2022-12-27","recordDate":"2022-12-28","paymentDate":"2022-12-30","value":1.11096,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104548077","title":"Institutions Have Sold Over $100 Billion in US Stocks, Goldman Sachs Suggests April Rebound Window May Be Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1104548077","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104548077?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:25","pubTimestamp":1774610708,"startTime":"0","endTime":"0","summary":"A wave of deleveraging is sweeping through the US stock market, with analysts suggesting that selling pressure may be nearing its limit. The S&P 500 index has declined by 5.8% over the past month,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","LU2750360641.GBP","BK4533","LU0061475181.USD","LU1791807156.HKD","LU2471134952.CNY","IE0002270589.USD","LU0251131958.USD","LU1804176565.USD","CTA","LU1894683348.USD","GSX","LU1668664300.SGD","LU2471134879.HKD","LU2237438978.USD","LU2237443465.HKD","IE0004091025.USD","LU2237443895.HKD","IE0034235188.USD","IE00BSNM7G36.USD","LU2237443549.SGD","BK4552","IE00B19Z3B42.SGD","IE0004086264.USD","GS","LU0048573561.USD","LU2265009873.SGD","LU2750360997.AUD","BK4585","IE00B19Z3581.USD","BK4516","LU0096364046.USD","LU2237443978.SGD","LU1868836757.USD","LU1894683264.USD","LU0345770308.USD","LU1868837300.USD","LU2237443382.USD","BK4504","LU0106831901.USD","LU1868836591.USD","LU2471134523.USD","IE00BFXG1179.USD","LU0345770993.USD","LU0742534661.SGD","LU2471134796.USD","LU0251142724.SGD","LU1868836914.USD","BK4550","BK4588","LU1868837136.USD","LU2237443622.USD"],"gpt_icon":0},{"id":"1165530293","title":"Unveiling the Liquidation Storm Behind High Leverage in Precious Metals","url":"https://stock-news.laohu8.com/highlight/detail?id=1165530293","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165530293?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:11","pubTimestamp":1773832267,"startTime":"0","endTime":"0","summary":"The precious metals market recently underwent a dramatic upheaval. Analysis suggests the sharp retracement in gold and silver prices in late January was not coincidental, with the core drivers being...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIS","CTA","NAV"],"gpt_icon":0},{"id":"1123181754","title":"Hedge Funds Suffer Worst Losses Since \"Liberation Day\" as Iran Conflict Upends Traditional Diversification","url":"https://stock-news.laohu8.com/highlight/detail?id=1123181754","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123181754?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:08","pubTimestamp":1773817731,"startTime":"0","endTime":"0","summary":"Hedge funds have been severely impacted by the escalation of the Iran conflict, as a surge in oil prices and a broad market sell-off caused crowded trades to unravel. Since the conflict began, hedge...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cc3b03ca23b36aa5c2cdfaceb35bce20","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","SG9999002224.SGD","LU2237443895.HKD","LU2746668974.SGD","LU1267930490.SGD","LU0882574139.USD","IE00BDRTCR15.USD","LU1261432733.SGD","IE0034235295.USD","LU1366192091.USD","BK4581","LU2552382058.USD","BK4588","LU2023250504.SGD","IE000M9KFDE8.USD","LU2381873111.SGD","LU2237443549.SGD","LU2237443622.USD","LU1244550221.USD","IE00BFXG1179.USD","LU0203345920.USD","LU2237443382.USD","LU0942090050.USD","LU1720051108.HKD","LU2023250330.USD","LU2242649171.HKD","LU1629891620.HKD","LU0964807845.USD","LU0265550946.USD","LU0234572021.USD","LU0310799852.SGD","LU0215105999.USD","LU0323591593.USD","BK4534","LU0211328371.USD","LU1974910355.USD","IE00B775SV38.USD","LU1894683348.USD","LU2456880835.USD","BK4566","LU0006306889.USD","LU0787776722.HKD","LU2552382132.HKD","IE0034235303.USD","LU0320765489.SGD","LU0971096721.USD","IE00B3S45H60.SGD","LU2462157665.USD","LU0496365809.HKD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU0106261372.USD","LU1548497426.USD","LU2357305700.SGD","LU0208291251.USD","JPMO","LU0868494617.USD","IE00BKVL7J92.USD","LU1145028129.USD","LU2505996509.AUD","LU1116320901.HKD","IE00BHPRN162.USD","LU1668664300.SGD","LU0070302665.USD","LU2552382215.SGD","LU0820562030.AUD","BK4533","LU1551013425.SGD","LU0211326839.USD","LU2211815571.USD","LU1280957306.USD","LU1914381329.SGD","LU2236285917.USD","BK4516","LU0345769631.USD","CTA","LU0345769128.USD","LU0106831901.USD","LU1116320737.USD","IE00BBT3K403.USD","LU0048584097.USD","LU0203347892.USD","LU1119994496.HKD","LU2430703251.USD","IE00BKDWB100.SGD","LU0211327993.USD","LU0868494708.USD","LU2106854487.HKD","IE00BWXC8680.SGD","LU2505996681.GBP","LU1162221912.USD","IE00BZ1G4Q59.USD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU0170899867.USD","LU0251132253.USD","JPM","LU2213496289.HKD","IE00B1XK9C88.USD","LU2756315318.SGD","IE00BYXW3230.USD","LU1363072403.SGD","LU1064131342.USD","LU0345770308.USD","IE0034235188.USD","LU2430703178.SGD","LU0267386448.USD","LU0211326755.USD","LU2264538146.SGD","LU1720051017.SGD","LU0256863811.USD","LU2417539215.USD","LU0689472784.USD","LU2054465674.USD","LU0976567544.SGD","LU1496350502.SGD","LU2237443465.HKD","LU0640476718.USD","LU1244550577.SGD","LU1988902786.USD","BK4585","LU1670628061.USD","LU2746668461.USD","LU2237443978.SGD","LU0943347566.SGD","LU0320765646.SGD","LU1084165304.USD","LU1917777945.USD","LU0149725797.USD","LU1551013342.USD","LU0683600562.USD","LU2023250843.SGD","LU2592432038.USD","IE00BJTD4N35.SGD","LU2756315664.SGD","BK4550","LU1032466523.USD","LU2430703095.HKD","LU0345770993.USD","LU1670627923.USD","BK4207","LU0417517546.SGD","BK4504","LU0211331839.USD","LU1496350171.SGD","LU1894683264.USD","LU0238689110.USD","IE00BDCRKT87.USD","LU0820561909.HKD","SG9999002232.USD","LU0265550359.USD","IE00BJLML261.HKD","LU1244550494.USD","IE00BJTD4V19.USD"],"gpt_icon":0},{"id":"1108409237","title":"Goldman Sachs Trader Warns: Market Correction Not Over, CTA Strategies Still Face Nearly $100 Billion in Pending Sell Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1108409237","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108409237?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:44","pubTimestamp":1773668691,"startTime":"0","endTime":"0","summary":"The U.S. stock market correction has not yet reached its bottom, with mechanical selling pressure continuing to build. The latest analysis from Goldman Sachs' derivatives and trading team indicates...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251131958.USD","IE00BFXG1179.USD","LU1868836757.USD","CTA","GSX","IE0004086264.USD","LU2237443549.SGD","LU1868837300.USD","BK4552","LU1804176565.USD","LU2237443978.SGD","LU1791807156.HKD","BK4516","BK4588","LU0345770308.USD","LU2237443895.HKD","LU0061475181.USD","LU0106831901.USD","IE00B19Z3581.USD","IE0004091025.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","GS","LU0742534661.SGD","LU1668664300.SGD","LU1894683264.USD","LU2237443622.USD","LU2471134796.USD","LU0048573561.USD","LU2750360997.AUD","BK4550","LU1894683348.USD","LU2237438978.USD","LU0345770993.USD","LU1868836591.USD","LU1868837136.USD","LU0251142724.SGD","BK4585","LU2471134523.USD","LU2471134879.HKD","IE0002270589.USD","LU1868836914.USD","BK4127","IE0034235188.USD","BK4533","LU2237443382.USD","LU2265009873.SGD","LU2750360641.GBP","LU0096364046.USD","LU2471134952.CNY","BK4504","LU2237443465.HKD"],"gpt_icon":0},{"id":"2619500464","title":"Press Release: Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2619500464","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619500464?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:00","pubTimestamp":1773662400,"startTime":"0","endTime":"0","summary":"Coya Therapeutics, Inc.  , a clinical-stage biotechnology company developing biologics intended to enhance T-cell  function in patients with neurodegenerative disorders, provides a corporate update and announces its financial results for the year ended December 31, 2025.--  Successfully launched the ALSTARS Phase 2 trial evaluating COYA. 302 for the treatment of ALS and now actively enrolling and dosing. patients across 25 clinical sites in the U.S. and Canada.--  Clinical Trial Application  acceptance from Health Canada. to proceed with the COYA 302 ALSTARS Phase 2 trial in Canada.--  Announced COYA 302 ALS trial acceptance by NEALS as a. --  Announced U.S. FDA acceptance of Investigation New Drug . Application for COYA 302 for the treatment of frontotemporal. and brain anti-inflammatory activity and enhanced Treg cell. function in an in vivo lipopolysaccharide  preclinical mouse. --  Published results in Frontiers in Immunology linking. inflammation and oxidative stress to the progre","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4139","IND","COYA","CTA"],"gpt_icon":0},{"id":"1195532110","title":"Oil Price Surge Triggers Asia-Pacific Market Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1195532110","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195532110?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:26","pubTimestamp":1773311161,"startTime":"0","endTime":"0","summary":"Oil price shocks continue to reverberate across markets. During early Asia-Pacific trading, Brent crude futures extended gains, surging by 10% intraday to reach $101.59 per barrel. Reports indicate...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"fd61dc47c6bb3500a9d72f9b5ab7f370","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"gpt_icon":0},{"id":"1102480808","title":"Hedge Funds Face Largest Drawdown Since April Last Year, Particularly Equity Long-Short Strategies Overweight in Europe and Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=1102480808","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102480808?lang=en_us&edition=fundamental","pubTime":"2026-03-12 08:10","pubTimestamp":1773274235,"startTime":"0","endTime":"0","summary":"Hedge funds are experiencing their most severe drawdown since last year's tariff disputes, with concentrated unwinding of crowded trades causing significant losses for this fast-money sector....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930490.SGD","LU2237443978.SGD","LU1551013425.SGD","LU2756315318.SGD","LU1116320901.HKD","LU2213496289.HKD","LU2237443549.SGD","LU0964807845.USD","LU0070302665.USD","LU2462157665.USD","LU0149725797.USD","IE00BDCRKT87.USD","LU0323591593.USD","LU1670627923.USD","LU1894683348.USD","SG9999002232.USD","IE00BJTD4V19.USD","LU2023250843.SGD","IE00BJLML261.HKD","LU0942090050.USD","LU1261432733.SGD","LU1894683264.USD","LU0211327993.USD","BK4588","IE00BWXC8680.SGD","LU0234572021.USD","LU0106831901.USD","LU2023250330.USD","LU2211815571.USD","LU2552382058.USD","LU1366192091.USD","LU0208291251.USD","LU0820562030.AUD","JPMO","LU0211326755.USD","IE00BJTD4N35.SGD","BK4534","IE00BBT3K403.USD","LU2237443622.USD","LU2381873111.SGD","LU1917777945.USD","LU0215105999.USD","LU1280957306.USD","LU1720051017.SGD","LU0211328371.USD","LU2430703095.HKD","LU0251132253.USD","LU0417517546.SGD","LU1064131342.USD","LU1145028129.USD","BK4566","BK4207","IE0034235303.USD","LU0320765646.SGD","IE00B1BXHZ80.USD","LU2746668974.SGD","IE00BLSP4239.USD","LU0943347566.SGD","LU1084165304.USD","LU1496350171.SGD","LU0345770308.USD","LU0496365809.HKD","BK4585","LU2357305700.SGD","LU0345769631.USD","LU1244550577.SGD","IE0034235295.USD","IE00BDRTCR15.USD","LU1988902786.USD","LU2236285917.USD","LU0976567544.SGD","LU1551013342.USD","LU0345770993.USD","LU1496350502.SGD","LU2505996509.AUD","LU1363072403.SGD","LU2264538146.SGD","LU0256863811.USD","LU0882574139.USD","LU2237443465.HKD","LU2054465674.USD","LU1668664300.SGD","LU2242649171.HKD","CTA","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0048584097.USD","LU1119994496.HKD","IE0034235188.USD","IE00B1XK9C88.USD","LU1116320737.USD","LU1914381329.SGD","IE00B3S45H60.SGD","IE00BKDWB100.SGD","LU0203347892.USD","LU2237443895.HKD","LU0006306889.USD","LU2106854487.HKD","LU0211326839.USD","BK4533","LU0238689110.USD","LU0265550946.USD","LU2237443382.USD","LU0310799852.SGD","IE00BN8TJ469.HKD","IE00BHPRN162.USD","LU2456880835.USD","LU0211331839.USD","LU2505996681.GBP","LU1548497426.USD","LU0267386448.USD","LU0820561909.HKD","LU1162221912.USD","BK4504","LU2023250504.SGD","LU1244550221.USD","LU0320765489.SGD","IE00BYXW3230.USD","LU0820561818.USD","LU0868494617.USD","LU0683600562.USD","LU2430703251.USD","LU2746668461.USD","LU0345769128.USD","BK4581","LU2756315664.SGD","LU0106261372.USD","LU0689472784.USD","LU1629891620.HKD","IE00B775SV38.USD","LU2417539215.USD","LU0265550359.USD","IE00BKVL7J92.USD","LU1720051108.HKD","IE00BFXG1179.USD","SG9999002224.SGD","JPM","LU2552382132.HKD","LU0203345920.USD","BK4516","LU0640476718.USD","LU0787776722.HKD","BK4550","LU1032466523.USD","LU2430703178.SGD","LU0170899867.USD","LU1244550494.USD","LU0868494708.USD","LU0971096721.USD","LU1974910355.USD","LU2552382215.SGD","LU1670628061.USD","LU2592432038.USD"],"gpt_icon":0},{"id":"1183313210","title":"Systemic Selling Pressure Set to Intensify as Major Banks Warn of Structural Vulnerabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=1183313210","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183313210?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:48","pubTimestamp":1773143322,"startTime":"0","endTime":"0","summary":"Despite a brief lift in risk sentiment following signals of de-escalation in the Middle East, recent trading desk alerts from Goldman Sachs and JPMorgan indicate that deeper structural issues in the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"gpt_icon":0},{"id":"2618625435","title":"Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2618625435","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618625435?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:00","pubTimestamp":1773057600,"startTime":"0","endTime":"0","summary":"-- Company will trade on Nasdaq under trading symbol \"DMRA\" effective March 10, 2026 -- -- On track to submit IND or CTA for DMR-001 in mutant-calreticulin essential thrombocythemia and myelofibrosis ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251772/0/en/Galecto-Announces-Name-Change-to-Damora-Therapeutics-with-Mission-to-Fundamentally-Redefine-Care-for-Patients-with-Blood-Disorders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4590","BK4585","DMRA","BK4581","IND","XELA","BK4588","ET","BK4106","BK4539","CTA","GLTO","LENZ","BK4561","BK4144","BK4139","BK4226"],"gpt_icon":0},{"id":"2617866576","title":"Press Release: Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2617866576","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617866576?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:05","pubTimestamp":1772744700,"startTime":"0","endTime":"0","summary":"Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus  in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outside North America Anticipated Year-End 2026. Physician KOLs Underscored the Need for a New Optimized HCV Regimen to Address Treatment Paradigm Shifts, Including Test-and-Treat Model of Care. Expanded Antiviral Pipeline with New Hepatitis E Virus  Program; Lead Product Candidate AT-587 Expected to Enter Clinic Mid-2026. Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination  of bemnifosbuvir  and ruzasvir  for the treatment of chronic HCV. The global Phase 3 program consists of two open-label controlled trials: C-BEYOND in North America and C-FORWARD outside North America. In 2025, Atea advanced enrollment across both trials. The Company completed C-BEYOND enrollment in December 2025 with over 880 patients and C-FORWARD is expected to complete enrollment mid-2","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4007","IND","R","CTA","BK4085","DDI","BK4022","AVIR"],"gpt_icon":0},{"id":"2616349328","title":"Press Release: Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349328","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616349328?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:00","pubTimestamp":1772542800,"startTime":"0","endTime":"0","summary":"-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 --. -- Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment --. -- Prime Medicine reported cash, cash equivalents, investments, and restricted cash of $191M providing cash runway into 2027 --. CAMBRIDGE, Mass., March 03, 2026  -- Prime Medicine, Inc. , a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results for the full year ended December 31, 2025 and provided a business update.Prime Medicine is advancing in vivo gene editing programs aimed at treating two of the most significant genetic liver disorders: Wilson Disease  and Alpha--1 Antitrypsin Deficiency . Prime Medicine anticipates submitting an investigational new drug  and/or clinical trial application  for its anchor WD program  in the first half","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4588","CF","WD","CTA","IND","LU2463526074.USD","PRME","BK4195","BK4139","BK4585","BK4229","ASH","BK4093"],"gpt_icon":0},{"id":"2614472476","title":"Pew Applauds Milestone Ratification of International Treaty to Improve Safety at Sea","url":"https://stock-news.laohu8.com/highlight/detail?id=2614472476","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614472476?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:55","pubTimestamp":1771977300,"startTime":"0","endTime":"0","summary":"International Maritime Organization's Cape Town Agreement will help save lives and fight illegal fishing—protecting the ocean and the people who depend on it. LONDON, Feb. 25, 2026 /PRNewswire/ -- The Pew Charitable Trusts today welcomed the news that theCape Town Agreement has received sufficient support from major fishing nations across the globe—including Argentina, which acceded to the treaty today—to begin to be enforced starting next year. This binding international treaty will improve fishing vessel standards to ensure crew and observer safety and is an important step forward for the fight against illegal, unreported, and unregulated  fishing.The CTA will protect fishers' lives by establishing standards for industrial vessel construction and related seaworthiness, decking, heating, emergency procedures and other safety and life-saving measures. Before this landmark treaty, few global standards or international legal obligations protected fishers at sea. Research from the FISH Sa","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pew-applauds-milestone-ratification-of-international-treaty-to-improve-safety-at-sea-302696377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"gpt_icon":0},{"id":"2602171275","title":"XTransfer Debuts at the CES in Vegas","url":"https://stock-news.laohu8.com/highlight/detail?id=2602171275","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602171275?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:48","pubTimestamp":1768222080,"startTime":"0","endTime":"0","summary":"Accelerating Expansion into the U.S. Market to Empower Cross-Border Payments in China–U.S. TradeLAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- XTransfer, the world's leading B2B cross-border trade payment platform, made its debut as an exhibitor at the Consumer Electronics Show  in Las Vegas. This appearance marks XTransfer's acceleration into the North and South American markets and its commitment to providing Chinese and U.S. foreign trade enterprises with secure, compliant, and efficient cross-border payment solutions, facilitating smoother global trade fund flows.XTransfer participates in CES in the U.S. for the first time. The team at “CES 2026 Asia Night”.As the world's largest and most influential trade show for electronics and technology, CES brings together technology companies, innovators, and industry professionals from around the globe and serves as a key platform to showcase cutting-edge technologies and business solutions. At CES 2026, XTransfer will comprehensively present its","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2859245/CES_Asia_Night_XT_2026_3.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2859245/CES_Asia_Night_XT_2026_3.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/xtransfer-debuts-at-the-ces-in-vegas-302658489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTA"],"gpt_icon":0},{"id":"2601897745","title":"Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897745","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897745?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:00","pubTimestamp":1767704400,"startTime":"0","endTime":"0","summary":"Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle (TV)-enabled investigational therapy for Hunter syndromeExpecting multiple clinical data readouts from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/06/3213572/0/en/Denali-Therapeutics-Announces-Key-Anticipated-Milestones-and-Priorities-for-2026-Including-Commercial-Launch-of-Tividenofusp-Alfa-for-Hunter-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","ETV","BK4548","IND","BK4535","BK4100","TV","BK4007","BK4139","CTA","DNLI"],"gpt_icon":0},{"id":"1135583863","title":"CES Chairperson: Robots Take Center Stage This Year | On the Ground at CES","url":"https://stock-news.laohu8.com/highlight/detail?id=1135583863","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135583863?lang=en_us&edition=fundamental","pubTime":"2026-01-06 02:20","pubTimestamp":1767637229,"startTime":"0","endTime":"0","summary":"Gary Shapiro, Executive Chairman and CEO of the Consumer Technology Association (CTA), the organizer of CES 2026, stated that the core theme of this year's show is the practical application of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4588","CTA","BK4543","AI","BK4585","BK4587","BK4528","BK4551"],"gpt_icon":0},{"id":"2601886576","title":"Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886576","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601886576?lang=en_us&edition=fundamental","pubTime":"2026-01-05 20:00","pubTimestamp":1767614400,"startTime":"0","endTime":"0","summary":"Randomized 6-month data from the REMAIN-1 Midpoint Cohort expected in late January 2026 Topline 6-month data from the REMAIN-1 Pivotal Cohort and potential PMA submission expected in H2 2026 Approxima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/05/3212610/0/en/Fractyl-Health-Enters-a-Catalyst-Rich-2026-Positioned-to-Define-the-Post-GLP-1-Weight-Maintenance-Therapeutic-Category.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4082","BK4212","BK4144","IND","BK4590","GUTS","CTA","GLP"],"gpt_icon":0},{"id":"2600060509","title":"WHAT NOT TO MISS AT CES 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060509","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600060509?lang=en_us&edition=fundamental","pubTime":"2026-01-03 03:27","pubTimestamp":1767382020,"startTime":"0","endTime":"0","summary":"Innovators Show Up for theWorld's Most Powerful Tech Event Returning to Las Vegas January 6-9. ARLINGTON, Va., Jan. 3, 2026 /PRNewswire/ --CES 2026, the world's most powerful tech event, returns to Las Vegas, January 6-9, bringing together global companies, innovative startups, industry executives, global media, and government leaders to experience the next-generation of tech that will solve global challenges.\"CES 2026 is where innovators show up – to connect, forge partnerships, and do business on a global scale,\" said Gary Shapiro, Executive Chair and CEO, Consumer Technology Association , owner and producer of CES. \"All signs point to a phenomenal CES with thousands of exhibitors, a record 3600+ Innovation Award submissions, and innovation across 13 venues and 2.6M net square feet. This is an exciting time for innovation and CES 2026 will have the latest tech in AI, robotics, digital health, mobility, enterprise, energy, immersive entertainment, accessibility, and more.\". CES Access","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2520236/5699896/CESLogo_CLR_RGB_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2520236/5699896/CESLogo_CLR_RGB_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/what-not-to-miss-at-ces-2026-302651861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AI","BK4551","BK4588","IPS","CTA","EIC","BK4077","MI","BK4021","BK4023","BK4585","BK4587","BK4543","NM","BK4528"],"gpt_icon":0},{"id":"2592181405","title":"Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2592181405","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592181405?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:05","pubTimestamp":1766091900,"startTime":"0","endTime":"0","summary":"Reinforces Role of AI-Powered Quantitative Coronary Plaque AssessmentMOUNTAIN VIEW, Calif., Dec.  18, 2025  (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3208182/0/en/Heartflow-Plaque-Analysis-Now-Supported-by-Scientific-Statements-From-American-College-of-Cardiology-and-American-Heart-Association-for-Personalized-Management-of-Patients-with-Sus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4588","BK4023","BK4587","HTFL","BK4585","BK4543","CTA","AFG","BK4107","AI","BK4551","BK4167","BK4117"],"gpt_icon":0},{"id":"2590315510","title":"VSure and HEYDOC Health Introduce CareConnect Suite, Transforming SME Protection and Digital Healthcare in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315510","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590315510?lang=en_us&edition=fundamental","pubTime":"2025-12-09 15:58","pubTimestamp":1765267080,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia, Dec. 9, 2025 /PRNewswire/ -- In a move that reflects the shifting expectations of Malaysia's modern workforce,VSure Group and virtual healthcare provider HEYDOC Health have jointly launched CareConnect Suite, a new digital ecosystem aimed at closing long-standing gaps in employee benefits for small and medium enterprises .The foundation of CareConnectSuite is the combination of EzPA — VSure's uniquely curated, affordable and accessible PA protection with hospital income benefit — and FutureK, HEYDOC Health's digitally integrated outpatient care model.\"The majority of Malaysia's workforce sits within SMEs, but access to traditional employee benefits has not kept pace with their needs,\" said Eddy Wong, Co-Founder & CEO of VSure Group. \"CareConnect Suite is our way of offering SMEs a realistic path forward — something affordable, something simple, and something that actually works for their teams.\"The solution also extends beyond employers. Freelancers, gig-workers","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2841316/P1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2841316/P1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/vsure-and-heydoc-health-introduce-careconnect-suite-transforming-sme-protection-and-digital-healthcare-in-malaysia-302636302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4137","HCSG","XBI","BK4588","BK4581","BK4585","LU0029874061.USD","XLV","LABU","CTA"],"gpt_icon":0},{"id":"2589060328","title":"ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2589060328","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589060328?lang=en_us&edition=fundamental","pubTime":"2025-12-08 06:08","pubTimestamp":1765145280,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ --Telix Pharmaceuticals Limited  today announces that the first patienthas been dosed in Part 2  of its ProstACT Global Phase 3 study evaluating its lead prostate cancer therapy candidate TLX591  in patients with metastatic castration resistant prostate cancer . The patient was dosed at the Australian Prostate Centre  in Melbourne, Australia.ProstACT Global is the first Phase 3 trial to combine aPSMA[1]-targeted radio antibody-drug conjugate  therapy administered together with Standard of Care  versus SOC alone. Part 2 of ProstACT Global will enroll approximately 490 patients and is currently recruiting patients in Australia, New Zealand and Canada.As previously agreed with FDA and disclosed to the market, Telix will submit Part 1 data to the United States  Food and Drug Administration  to enable clearance to expand Part 2 of the trial to U.S. sites. A public disclosure of preliminary results from Part 1 of the study will","market":"sg","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/prostact-global-phase-3-update-first-patient-dosed-in-randomized-treatment-expansion-part-1-readout-plans-confirmed-302634831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2083900584.USD","ASX","RLT.AU","LU1718418525.SGD","EMA.AU","LU2236285917.USD","LU1778281490.HKD","LU1066053197.SGD","XAO.AU","LU0053666078.USD","LU0170899867.USD","TLX.AU","LU1366192091.USD","LU2237443549.SGD","APC","APC.AU","BK7142","CTA","XKO.AU","XJO.AU","LU1935043536.SGD","TLX","LU1935042991.SGD","EMA","BK7095","BK7067","BK4141","LU0077335932.USD","LU2420271590.USD","LU1066051225.USD","LU2456880835.USD","LU0149725797.USD","LU2237443622.USD","LU2237443978.SGD","LU1674673691.USD","LU1935043023.USD","BK4526","LU1066051811.HKD","LU1935042488.USD","LU1066051498.USD","SEC.AU","LU0882574139.USD","LU0314104364.USD","BK4543","LU2237443382.USD","ASX.AU","LU0786609619.USD","BK4139","BK7129","LU1496350171.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}